Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan

Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan

In terms of sacubitril/valsartan (S/V)-induced changes in heart failure with reduced ejection fraction (HFrEF) via three-dimensional (3D) transthoracic echocardiography (TTE) and S/V effects based on HF aetiology, data are lacking. We prospectively enrolled 51 HFrEF patients (24 ischaemic, 27 non-is...

Full description

Bibliographic Details
Main Authors: Valentina Mantegazza, Valentina Volpato, Massimo Mapelli, Valentina Sassi, Elisabetta Salvioni, Irene Mattavelli, Gloria Tamborini, Piergiuseppe Agostoni, Mauro Pepi
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Diagnostics
Subjects:
sacubitril/valsartan
heart failure with reduced ejection fraction
heart failure aetiology
reverse remodelling
3D echocardiography
Online Access:https://www.mdpi.com/2075-4418/11/10/1845

Internet

https://www.mdpi.com/2075-4418/11/10/1845

Similar Items